Take Your Trading To The Next Level. Get Started Here!

FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease

March 15, 2024 Comments Off

The FDA’s decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are still trying to break into.